Trevena, Inc., a clinical stage pharmaceutical company and the leader in the discovery and development of G-protein coupled receptor biased ligands, and Forest Laboratories Holding Limited, a subsidiary of Forest Laboratories Inc., an international pharmaceutical company, announced today that they have entered into a collaborative licensing option agreement for the development of TRV027, an AT1R biased-ligand that recently completed Phase 2a clinical trials.
[More]
The CCIM Institute has accepted UT Dallas as a university partner, putting graduate students in real estate on the fast track to earning its prestigious expert designation.
[More]
The protein tumor necrosis factor-alpha (TNF-alpha) is a powerful weapon in the arsenal to control cancer. Unfortunately, as is the case with many potent cancer therapies, the use of TNF-alpha as an anti-cancer therapy has been severely limited.
[More]
Good Start Genetics, Inc., an innovative molecular diagnostics company that has developed the new gold standard in carrier screening, today announced that it has closed a non-dilutive loan facility for up to $28 million of capital from Capital Royalty L.P.
[More]
Today, the Global Network for Neglected Tropical Diseases, a major initiative of the Sabin Vaccine Institute, announced His Excellency, President Alvaro Arz- Irigoyen of Guatemala (1996-2000), His Excellency, President Ricardo Lagos Escobar of Chile (2000-2006) and former Pan American Health Organization Director Dr. Mirta Roses Periago as the organization's newest Neglected Tropical Disease Special Envoys.
[More]
Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a biopharmaceutical company specializing in T-cell vaccines, today announced a $2.9 million grant to Aeras in support of a collaboration among the three parties to support the development of vaccines against tuberculosis, HIV and malaria.
[More]
In a world first, scientists from the Institute of Food Research (IFR) on the Norwich Research Park have been test-driving a prototype instrument that promises to revolutionise access to a potent laboratory analysis technique called NMR (Nuclear Magnetic Resonance).
[More]
Thanks to new federal funding, low-cost, easily accessible technology invented by a Simon Fraser University engineering professor and his graduate students is closer to helping to save millions of infant lives.
[More]
NeuroPhage Pharmaceuticals, Inc., a company developing breakthrough therapies for neurodegenerative diseases, today announced that it raised $6.4 million in a private equity financing round.
[More]
Comprehensive Care Corporation, a leading behavioral health, substance abuse and pharmacy management provider for employers, Taft-Hartley health and welfare Funds, and managed care companies, today announced that it has closed a $5 million Senior Secured Credit Facility with TCA Global Credit Master Fund (TCA).
[More]
National Health Investors, Inc. announced today its normalized Funds From Operations ("FFO"), its normalized Funds Available for Distribution ("FAD") and net income attributable to common stockholders for the three months ended March 31, 2013.
[More]
America's emergency, trauma and intensive care teams provide some of the world's most advanced care, bringing patients back from the brink of death on a regular basis.
[More]
Pediatricians, economists, social scientists and policy experts will come together on Saturday, May 4, to address one of the greatest threats to child health - poverty.
[More]
Aetna today announced the U.S. Department of Justice has cleared Aetna's proposed acquisition of Coventry Health Care, Inc. Aetna expects to complete its acquisition of Coventry within the next three business days.
[More]
Cambrex Corporation reports results for the first quarter ended March 31, 2013.
[More]
Citing data on how HIV/AIDS has affected children worldwide, whether directly or through the death of one or both parents, U.S. Global AIDS Coordinator Ambassador Eric Goosby, who also heads the State Department's Office of Global Health Diplomacy, writes in the agency's "DipNote" blog that children are vulnerable "to the social, emotional, economic, and environmental effects that HIV and AIDS has on families, communities, and countries."
[More]
Cancer Genetics, Inc., a leader in oncology-focused personalized medicine, has launched a proprietary urogenital cancer array, UroGenRA, intended for kidney cancer diagnosis and subtyping in its own laboratory.
[More]
Glide Pharma® today announced the award of a sub-contract from Pfenex Inc. to develop a solid formulation containing the recombinant Protective Antigen (rPA) from Bacillus anthracis expressed in Pfēnex Expression Technology™ suitable for delivery with the Glide SDI® (solid dose injector). This approach will address two important logistical constraints of the currently available vaccine, namely, long term stability during storage and ease of administration.
[More]
Last week, "[t]he George W. Bush Presidential Library dedication brought together five living presidents who have been at odds about much of the 43rd president's foreign policy legacy, particularly the Iraq war ... [b]ut they all agreed on, and offered effusive praise for, Bush's work on Africa," ABC News' "The Note" blog reports.
[More]
New statistics released by the American Society of Plastic Surgeons show that arm lifts in women have skyrocketed more than 4,000 percent in just over the last decade.
[More]